Transcode Therapeutics RNAZ
NASDAQ RNAZ
$1.65 +0.02 (+1.23%)
As of: Sep 30, 2026 · 3:51 PM EDT

Transcode Therapeutics (RNAZ) Non-Current Assets (2020 - 2026)

Updated

Transcode Therapeutics' Non-Current Assets came in at $140.37 million for Q2 2026, compared with $24,689 a year earlier and unchanged from the prior quarter.

Analysis

Transcode Therapeutics (RNAZ) Non-Current Assets (2020 - 2026) Analysis & Trends

At the end of FY2025, Transcode Therapeutics' Non-Current Assets was $140.41 million.

  • Non-Current Assets carries a five-year compound annual growth rate of 262.6% (FY2020 to FY2025).
  • Going back by year, Non-Current Assets was $201,161 in FY2024 (-71.8%), $714,257 in FY2023 (+242.4%), $208,581 in FY2022 (+1.1%) and $206,268 in FY2021 (-8.0%).
  • The five-year range for quarterly Non-Current Assets is $24,689 (Q2 2025) to $140.42 million (Q1 2026).
  • Year-over-year, Non-Current Assets increased in 1 of the last five quarters, with an average decline of 51.1%.
  • The fastest year-over-year change in Non-Current Assets over five years came in Q1 2023 (growth of 477.7%), and the weakest in Q2 2025 (a decline of 94.4%).
  • Business Quant data shows RNAZ's Non-Current Assets at $140.42 million (Q1 2026), $140.41 million (Q4 2025) and $475,634 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 141.29 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 101.45 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 125.00 Mn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 94.68 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 87.87 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 60.68 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 35.42 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 159.77 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 14.88 Bn
10 Transcode Therapeutics 1.65 Mn 1.65 Mn - 140.37 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 140.37 Mn
Mar 31, 2026 140.42 Mn
Dec 31, 2025 140.41 Mn
Sep 30, 2025 475,634.00
Jun 30, 2025 24,689.00
Mar 31, 2025 149,987.00
Dec 31, 2024 201,161.00
Sep 30, 2024 323,516.00
Jun 30, 2024 438,167.00
Mar 31, 2024 576,445.00
Dec 31, 2023 714,257.00
Sep 30, 2023 854,430.00
Jun 30, 2023 988,608.00
Mar 31, 2023 1.24 Mn
Dec 31, 2022 208,581.00
Sep 30, 2022 445,688.00
Jun 30, 2022 234,673.00
Mar 31, 2022 215,324.00
Dec 31, 2021 206,268.00
Sep 30, 2021 155,610.00
API Access

Transcode Therapeutics Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-assets&ticker=RNAZ&period=max&api_key=YOUR_API_KEY